Adaptation of the P1 phage-derived Cre/loxP site-specific recombinatio
n system to the gene targeting technique allows for the conditional de
letion of genes in mice. To selectively modify genes in B lymphocytes,
we have generated mice (designated CD19-Cre) which express cre under
the transcriptional control of the B lineage-restricted CD19 gene. In
a model system involving the cross of CD19-Cre mice with mice bearing
a loxP-flanked substrate, we find a deletion efficiency of 75-80% in b
one marrow-derived pre-B cells that increases to 90-95% in splenic B c
ells.